1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECH
  4. PROTAGONIST THERAPEUTICS INC
Protagonist Therapeutics Inc XNAS: PTGX
Turnaround Potential
Download real time
55.69 0.47 (0.85%)
77.70% Gain from 52W Low
1.5M
XNAS Volume

XNAS 27 Jun, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Share
Board Meeting
The next board meeting for Protagonist Therapeutics Inc is on 30 Jun 2025 for the purpose of Oral obesity development candidate and to share in vitro and pre-clinical proof-of-concept study results See details

Protagonist Therapeutics Inc - PTGX - stock price prediction, stock price target, analyst ratings from 11 analysts

Protagonist Therapeutics Inc has a share price target of US$ 69, revenue growth forecast of -81.3%, and profit growth estimate of -140.8% for FY25, based on top 11 analyst calls.

Forecaster Screeners